| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2796810 | Diabetes Research and Clinical Practice | 2013 | 4 Pages |
Abstract
C peptide (CP) was evaluated in 88 individuals with type 1 diabetes, variable disease duration and multiethnic background. Initially, 28 patients had detectable CP, which persisted in 46.2% after 17.4 ± 4 months. CP decline was associated with ethnicity, HbA1c and baseline CP, but not with GADA, PTPN22 or insulin gene polymorphisms.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Joana R. Dantas, Mirella H. Almeida, Bianca Barone, Fabiano Serfaty, Luis R. Raggio, Rosane Kupfer, Lenita Zajdenverg, José E.P. Oliveira, Melanie Rodacki,